BNTC — Benitec Biopharma Share News
0.000.00%
Last trade - 00:00- $301.79m
- $121.82m
Benitec Biopharma Q3 net loss narrows as expenses fall
Benitec Biopharma Q2 net loss widens
Brief: Benitec Biopharma Q2 Operating Income USD -13.4 Million
Biotech firm Benitec's fiscal Q1 net loss widens
Brief: Benitec Biopharma Q1 EPS USD -0.22
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm
U.S. STOCKS ON THE MOVE-Cummins, EPAM Systems, Qualcomm
Benitec Biopharma tumbles on $100 mln stock offering
Brief: Benitec Biopharma Announces Pricing Of $100 Million Common Stock Offering At $13.50 Per Share
Brief: Benitec Biopharma Inc. Announces Proposed Public Offering
Brief: Benitec Biopharma Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing
Brief: Benitec Biopharma Releases Full Year 2025 Financial Results
Brief: Benitec Biopharma Says Financial Statements For Three And Nine Months Ended March 31, 2025 December 31, 2024 Not Reliable - SEC Filing
Benitec Biopharma Inc reports results for the quarter ended March 31 - Earnings Summary
Brief: Benitec Biopharma Q3 Operating Income USD -10.2 Million
Benitec Biopharma Inc expected to post a loss of 35 cents a share - Earnings Preview
Benitec Biopharma Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Benitec Biopharma Releases Second Quarter 2025 Financial Results
Benitec Biopharma Inc expected to post a loss of 77 cents a share - Earnings Preview